COMMUNITY HEALTHCARE TRUST I (CHCT)
US20369C1062 - REIT
Overall CHCT gets a fundamental rating of 5 out of 10. We evaluated CHCT against 127 industry peers in the Diversified REITs industry. CHCT has a medium profitability rating, but doesn't score so well on its financial health evaluation. CHCT is not priced too expensively while it is growing strongly. Keep and eye on this one! Finally CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT was profitable.
CHCT had a positive operating cash flow in the past year.
Each year in the past 5 years CHCT has been profitable.
In the past 5 years CHCT always reported a positive cash flow from operatings.
1.2 Ratios
CHCT has a better Return On Assets (1.61%) than 61.60% of its industry peers.
Looking at the Return On Equity, with a value of 3.10%, CHCT is in line with its industry, outperforming 60.00% of the companies in the same industry.
CHCT has a Return On Invested Capital (3.00%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHCT is in line with the industry average of 3.00%.
The 3 year average ROIC (2.91%) for CHCT is below the current ROIC(3.00%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 3.1% | ||
| ROIC | 3% |
ROA(3y)1.8%
ROA(5y)1.84%
ROE(3y)3.07%
ROE(5y)3.04%
ROIC(3y)2.91%
ROIC(5y)2.96%
1.3 Margins
With a decent Profit Margin value of 13.79%, CHCT is doing good in the industry, outperforming 65.60% of the companies in the same industry.
In the last couple of years the Profit Margin of CHCT has declined.
With a decent Operating Margin value of 31.95%, CHCT is doing good in the industry, outperforming 70.40% of the companies in the same industry.
In the last couple of years the Operating Margin of CHCT has declined.
CHCT has a better Gross Margin (81.18%) than 80.00% of its industry peers.
In the last couple of years the Gross Margin of CHCT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.95% | ||
| PM (TTM) | 13.79% | ||
| GM | 81.18% |
OM growth 3Y-15.52%
OM growth 5Y-4.28%
PM growth 3Y-41.7%
PM growth 5Y-8.07%
GM growth 3Y-0.15%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHCT is destroying value.
The number of shares outstanding for CHCT has been increased compared to 1 year ago.
Compared to 5 years ago, CHCT has more shares outstanding
The debt/assets ratio for CHCT is higher compared to a year ago.
2.2 Solvency
CHCT has an Altman-Z score of 1.18. This is a bad value and indicates that CHCT is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.18, CHCT belongs to the best of the industry, outperforming 82.40% of the companies in the same industry.
CHCT has a Debt/Equity ratio of 0.87. This is a neutral value indicating CHCT is somewhat dependend on debt financing.
The Debt to Equity ratio of CHCT (0.87) is better than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.18 |
ROIC/WACC0.41
WACC7.32%
2.3 Liquidity
CHCT has a Current Ratio of 0.69. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CHCT (0.69) is worse than 80.80% of its industry peers.
A Quick Ratio of 0.23 indicates that CHCT may have some problems paying its short term obligations.
CHCT has a worse Quick ratio (0.23) than 96.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.69 | ||
| Quick Ratio | 0.23 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 110.34% over the past year.
The Earnings Per Share has been growing slightly by 1.25% on average over the past years.
CHCT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.44%.
Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 18.37% on average per year.
EPS 1Y (TTM)110.34%
EPS 3Y-39.18%
EPS 5Y1.25%
EPS Q2Q%134.38%
Revenue 1Y (TTM)13.44%
Revenue growth 3Y14.24%
Revenue growth 5Y18.37%
Sales Q2Q%7.94%
3.2 Future
Based on estimates for the next years, CHCT will show a very strong growth in Earnings Per Share. The EPS will grow by 70.85% on average per year.
Based on estimates for the next years, CHCT will show a quite strong growth in Revenue. The Revenue will grow by 12.93% on average per year.
EPS Next Y251.33%
EPS Next 2Y107.53%
EPS Next 3Y70.85%
EPS Next 5YN/A
Revenue Next Year8.87%
Revenue Next 2Y8.75%
Revenue Next 3Y11.36%
Revenue Next 5Y12.93%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
CHCT is valuated quite expensively with a Price/Earnings ratio of 38.46.
Compared to the rest of the industry, the Price/Earnings ratio of CHCT is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 28.05. CHCT is valued slightly more expensive when compared to this.
CHCT is valuated quite expensively with a Price/Forward Earnings ratio of 30.26.
73.60% of the companies in the same industry are more expensive than CHCT, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.07. CHCT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.46 | ||
| Fwd PE | 30.26 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHCT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.86 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHCT has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CHCT's earnings are expected to grow with 70.85% in the coming years.
PEG (NY)0.15
PEG (5Y)30.78
EPS Next 2Y107.53%
EPS Next 3Y70.85%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 7.97%, CHCT is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.85, CHCT pays a better dividend. On top of this CHCT pays more dividend than 81.60% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CHCT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.97% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.33%.
CHCT has paid a dividend for at least 10 years, which is a reliable track record.
As CHCT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)2.33%
Div Incr Years8
Div Non Decr Years8
5.3 Sustainability
CHCT pays out 309.52% of its income as dividend. This is not a sustainable payout ratio.
CHCT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP309.52%
EPS Next 2Y107.53%
EPS Next 3Y70.85%
COMMUNITY HEALTHCARE TRUST I
NYSE:CHCT (5/31/2024, 7:04:00 PM)
After market: 23.46 0 (0%)23.46
+0.53 (+2.31%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap649.84M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.97% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.46 | ||
| Fwd PE | 30.26 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.15
PEG (5Y)30.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.61% | ||
| ROE | 3.1% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 31.95% | ||
| PM (TTM) | 13.79% | ||
| GM | 81.18% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.69 | ||
| Quick Ratio | 0.23 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)110.34%
EPS 3Y-39.18%
EPS 5Y
EPS Q2Q%
EPS Next Y251.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.44%
Revenue growth 3Y14.24%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y